Related Articles
Evaluation of HER-2/neu status by real-time quantitative PCR in malignant cartilaginous tumors
Lack of prognostic relevance of Her-2/neu, topoisomerase IIα and EGFR in advanced ovarian carcinoma
DNA topoisomerase IIα (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: In vitro evidence for a ‘functional amplicon’ involving FAS, Her-2/neu and TOP2A genes
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer